The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036
收藏Protein Data Bank Japan2024-04-03 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/3qrj
下载链接
链接失效反馈官方服务：
资源简介：
The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036 Descriptor: 4-[4-({[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide, Tyrosine-protein kinase ABL1 Authors: Chan, W.W, Wise, S.C, Kaufman, M.D, Ahn, Y.M, Ensinger, C.L, Haack, T, Hood, M.M, Jones, J, Lord, J.W, Lu, W.P, Miller, D, Patt, W.C, Smith, B.D, Petillo, P.A, Rutkoski, T.J, Telikepalli, H, Vogeti, L, Yao, T, Chun, L, Clark, R, Evangelista, P, Gavrilescu, L.C, Lazarides, K, Zaleskas, V.M, Stewart, L.J, Van Etten, R.A, Flynn, D.L. Deposit date: 2011-02-18 Release date: 2011-06-01 Last modified: 2024-04-03 Method: X-RAY DIFFRACTION (1.82 Å) Cite: Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036. Cancer Cell, 19, 2011
创建时间：
2011-02-18
